VTV THERAPEUTICS INC- CL A (VTVT:NASDAQ)
$38.5 0.75 (1.9868%)
Analysed VTV THERAPEUTICS INC- CL A (VTVT:NASDAQ) News Sources
Wall Street Analysts See a 39.9% Upside in vTv Therapeutics (VTVT): Can the Stock Really Move This High?
20-04-2026
yahoo.com
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
07-04-2026
yahoo.com
Wall Street Analysts Think vTv Therapeutics (VTVT) Could Surge 31.58%: Read This Before Placing a Bet
02-04-2026
yahoo.com
vTv Therapeutics (VTVT) Reports $27M 2025 Net Loss Amid Cadisegliatin Advancements
18-03-2026
yahoo.com
Wall Street Analysts Believe vTv Therapeutics (VTVT) Could Rally 39.86%: Here's is How to Trade
17-03-2026
yahoo.com
vTv Therapeutics to Participate in the 38th Annual ROTH Conference
16-03-2026
yahoo.com
VTv Therapeutics: Q4 Earnings Snapshot
10-03-2026
yahoo.com
vTv Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
10-03-2026
yahoo.com
vTv Therapeutics (VTVT) Secures Global Partnership for PDE4 Inhibitor HPP737
04-03-2026
yahoo.com
vTv Therapeutics to Participate in Upcoming Investor Conferences
13-02-2026
yahoo.com
What is the current price of VTV THERAPEUTICS INC- CL A (VTVT:NASDAQ)?
The current price of VTV THERAPEUTICS INC- CL A (VTVT:NASDAQ) is $38.5.
VTV THERAPEUTICS INC- CL A (VTVT:NASDAQ) absolute price change since previous trading day?
The absolute price change of VTV THERAPEUTICS INC- CL A (VTVT:NASDAQ) since the previous trading day is $0.75.
VTV THERAPEUTICS INC- CL A (VTVT:NASDAQ) percentage price change since previous trading day?
The percentage price change of VTV THERAPEUTICS INC- CL A (VTVT:NASDAQ) since the previous trading day is 1.9868%.
What is the most recent average sentiment score for VTV THERAPEUTICS INC- CL A (VTVT:NASDAQ)?
The most recent average sentiment score for VTV THERAPEUTICS INC- CL A (VTVT:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for VTV THERAPEUTICS INC- CL A (VTVT:NASDAQ)?
The most recent sentiment for VTV THERAPEUTICS INC- CL A (VTVT:NASDAQ) is .
SEC-8K** Filing Available For VTV THERAPEUTICS INC- CL A (VTVT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.